| Bioactivity | Revatropate is an antimuscarinic compound. Revatropate has a much greater inhibitory effect on M1 and M3 receptors than on the M2 subtype. Revatropate is used in the study of urge urinary incontinence and functional bowel disorders[1]. |
| CAS | 149926-91-0 |
| Formula | C19H27NO4S |
| Molar Mass | 365.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Alabaster VA. Discovery & development of selective M3 antagonists for clinical use. Life Sci. 1997;60(13-14):1053-60. |
Revatropate
CAS: 149926-91-0 F: C19H27NO4S W: 365.49
Revatropate is an antimuscarinic compound. Revatropate has a much greater inhibitory effect on M1 and M3 receptors than
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.